Annual CAPEX
$11.00 K
-$187.00 K-94.44%
December 31, 2023
Summary
- As of February 7, 2025, RDHL annual capital expenditures is $11.00 thousand, with the most recent change of -$187.00 thousand (-94.44%) on December 31, 2023.
- During the last 3 years, RDHL annual CAPEX has fallen by -$53.76 million (-99.98%).
- RDHL annual CAPEX is now -99.98% below its all-time high of $53.77 million, reached on December 31, 2020.
Performance
RDHL CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CAPEX
N/A
June 1, 2024
Summary
- RDHL quarterly capital expenditures is not available.
Performance
RDHL Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CAPEX
N/A
June 1, 2024
Summary
- RDHL TTM capital expenditures is not available.
Performance
RDHL TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
RDHL CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -94.4% | - | - |
| 3 y3 years | -100.0% | - | - |
| 5 y5 years | -81.0% | - | - |
RDHL CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -94.4% | at low | ||||
| 5 y | 5-year | -100.0% | at low | ||||
| alltime | all time | -100.0% | at low |
RedHill Biopharma CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $11.00 K(-94.4%) | - | - |
| Jun 2023 | - | $7000.00(>+9900.0%) | $29.00 K(-85.4%) |
| Dec 2022 | $198.00 K(+72.2%) | $0.00(-100.0%) | $198.00 K(-1.5%) |
| Sep 2022 | - | $22.00 K(-86.5%) | $201.00 K(+0.5%) |
| Jun 2022 | - | $163.00 K(+1153.8%) | $200.00 K(+400.0%) |
| Mar 2022 | - | $13.00 K(+333.3%) | $40.00 K(-65.2%) |
| Dec 2021 | $115.00 K(-99.8%) | $3000.00(-85.7%) | $115.00 K(-28.6%) |
| Sep 2021 | - | $21.00 K(+600.0%) | $161.00 K(-84.5%) |
| Jun 2021 | - | $3000.00(-96.6%) | $1.04 M(-98.0%) |
| Mar 2021 | - | $88.00 K(+79.6%) | $52.44 M(-2.5%) |
| Dec 2020 | $53.77 M(>+9900.0%) | $49.00 K(-94.6%) | $53.77 M(-0.0%) |
| Sep 2020 | - | $901.00 K(-98.2%) | $53.79 M(+1.7%) |
| Jun 2020 | - | $51.40 M(+3506.9%) | $52.89 M(+3161.0%) |
| Mar 2020 | - | $1.43 M(+1995.6%) | $1.62 M(+699.0%) |
| Dec 2019 | $203.00 K(+250.0%) | $68.00 K(+6700.0%) | $203.00 K(+16.0%) |
| Sep 2019 | - | $1000.00(-99.2%) | $175.00 K(-1.1%) |
| Jun 2019 | - | $128.00 K(+2033.3%) | $177.00 K(+247.1%) |
| Mar 2019 | - | $6000.00(-85.0%) | $51.00 K(-12.1%) |
| Dec 2018 | $58.00 K(-95.1%) | $40.00 K(+1233.3%) | $58.00 K(+176.2%) |
| Sep 2018 | - | $3000.00(+50.0%) | $21.00 K(-98.1%) |
| Jun 2018 | - | $2000.00(-84.6%) | $1.09 M(-8.4%) |
| Mar 2018 | - | $13.00 K(+333.3%) | $1.19 M(+1.1%) |
| Dec 2017 | $1.18 M | $3000.00(-99.7%) | $1.18 M(-5.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2017 | - | $1.08 M(+954.9%) | $1.24 M(+602.3%) |
| Jun 2017 | - | $102.00 K(+56.9%) | $177.00 K(+47.5%) |
| Dec 2016 | $120.00 K(-92.7%) | $65.00 K(+550.0%) | $120.00 K(+114.3%) |
| Sep 2016 | - | $10.00 K(-37.5%) | $56.00 K(-42.3%) |
| Jun 2016 | - | $16.00 K(-44.8%) | $97.00 K(-93.9%) |
| Mar 2016 | - | $29.00 K(+2800.0%) | $1.59 M(-2.9%) |
| Dec 2015 | $1.63 M(+47.9%) | $1000.00(-98.0%) | $1.63 M(-3.0%) |
| Sep 2015 | - | $51.00 K(-96.6%) | $1.68 M(-36.6%) |
| Jun 2015 | - | $1.50 M(+1854.5%) | $2.66 M(+129.6%) |
| Mar 2015 | - | $77.00 K(+51.0%) | $1.16 M(+4.7%) |
| Dec 2014 | $1.10 M(+393.3%) | $51.00 K(-95.0%) | $1.10 M(+3.7%) |
| Sep 2014 | - | $1.02 M(>+9900.0%) | $1.07 M(+335.1%) |
| Jun 2014 | - | $5000.00(-80.0%) | $245.00 K(-0.8%) |
| Mar 2014 | - | $25.00 K(+108.3%) | $247.00 K(+10.3%) |
| Dec 2013 | $224.00 K(+107.4%) | $12.00 K(-94.1%) | $224.00 K(+4.2%) |
| Sep 2013 | - | $203.00 K(+2800.0%) | $215.00 K(+1691.7%) |
| Jun 2013 | - | $7000.00(+250.0%) | $12.00 K(-88.6%) |
| Mar 2013 | - | $2000.00(-33.3%) | $105.00 K(-2.8%) |
| Dec 2012 | $108.00 K(-40.3%) | $3000.00(>+9900.0%) | $108.00 K(+2.9%) |
| Sep 2012 | - | $0.00(-100.0%) | $105.00 K(0.0%) |
| Jun 2012 | - | $100.00 K(+1900.0%) | $105.00 K(+2000.0%) |
| Mar 2012 | - | $5000.00 | $5000.00 |
| Dec 2011 | $181.00 K | - | - |
FAQ
- What is RedHill Biopharma annual capital expenditures?
- What is the all time high annual CAPEX for RedHill Biopharma?
- What is RedHill Biopharma annual CAPEX year-on-year change?
- What is the all time high quarterly CAPEX for RedHill Biopharma?
- What is the all time high TTM CAPEX for RedHill Biopharma?
What is RedHill Biopharma annual capital expenditures?
The current annual CAPEX of RDHL is $11.00 K
What is the all time high annual CAPEX for RedHill Biopharma?
RedHill Biopharma all-time high annual capital expenditures is $53.77 M
What is RedHill Biopharma annual CAPEX year-on-year change?
Over the past year, RDHL annual capital expenditures has changed by -$187.00 K (-94.44%)
What is the all time high quarterly CAPEX for RedHill Biopharma?
RedHill Biopharma all-time high quarterly capital expenditures is $51.40 M
What is the all time high TTM CAPEX for RedHill Biopharma?
RedHill Biopharma all-time high TTM capital expenditures is $53.79 M